Immunoprecise Antibodies Ltd Stock Forecast, Predictions & Price Target

Analyst price target for IPA

Based on 2 analysts offering 12 month price targets for Immunoprecise Antibodies Ltd.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell IPA stock?

Based on 2 analysts offering ratings for Immunoprecise Antibodies Ltd.
Strong Buy
0 analysts 0%
2 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IPA stock forecasts and price targets.

IPA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
Bottom 11%

1 of 1

IPA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VTGN$5.25$30.00+471.43%Strong Buy

Immunoprecise Antibodies Stock Forecast FAQ

Is Immunoprecise Antibodies Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IPA) stock is to Buy IPA stock.

Out of 2 analysts, 0 (0%) are recommending IPA as a Strong Buy, 2 (100%) are recommending IPA as a Buy, 0 (0%) are recommending IPA as a Hold, 0 (0%) are recommending IPA as a Sell, and 0 (0%) are recommending IPA as a Strong Sell.

If you're new to stock investing, here's how to buy Immunoprecise Antibodies stock.

What is IPA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IPA price target, the average IPA price target is $8.00, with the highest IPA stock price forecast at $9.00 and the lowest IPA stock price forecast at $7.00.

On average, Wall Street analysts predict that Immunoprecise Antibodies's share price could reach $8.00 by Sep 18, 2024. The average Immunoprecise Antibodies stock price prediction forecasts a potential upside of 306.09% from the current IPA share price of $1.97.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.